Skip to main content
PMC home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1996 Sep;149(3):1063–1071.

Novel neuritic clusters with accumulations of amyloid precursor protein and amyloid precursor-like protein 2 immunoreactivity in brain regions damaged by thiamine deficiency.

N Y Calingasan 1, S E Gandy 1, H Baker 1, K F Sheu 1, J D Smith 1, B T Lamb 1, J D Gearhart 1, J D Buxbaum 1, C Harper 1, D J Selkoe 1, D L Price 1, S S Sisodia 1, G E Gibson 1
PMCID: PMC1865137  PMID: 8780408

Abstract

Experimental thiamine deficiency (TD) is a classical model of a nutritional deficit associated with a generalized impairment of oxidative metabolism and selective cell loss in the brain. In rats, TD-induced cell degeneration is accompanied by an accumulation of amyloid precursor protein (APP)/amyloid precursor-like protein 2 (APLP2) immunoreactivity in abnormal neurites and perikarya along the periphery of, or scattered within, the lesion. Prompted by these data and our previous findings of a genetic variation in the development of TD symptoms, we extended our studies to mice. C57BL/6, ApoE knockout, and APP YAC transgenic mice received thiamine-deficient diet and pyrithiamine injections. Unlike rats, APP/APLP2-immunoreactive neurites in all strains of mice were sparsely scattered within damaged areas and did not delimit the thalamic lesion. In addition, abnormal clusters of intensely immunoreactive neurites occurred only in areas of damage including the thalamus, mammillary body, and inferior colliculus. The clusters appeared as either irregular clumps or round or oval rosettes that strikingly resembled the neuritic component of Alzheimer amyloid plaques. However, immunostaining using various antisera to synthetic amyloid beta-protein (A beta 1-40) and thioflavine S histochemistry failed to show evidence of a component of A beta Neither APP/APLP2-immunoreactive clusters nor amyloid plaques were observed in the brain from patients with Wernicke-Korsakoff syndrome, the clinical manifestation of TD in man. Our results demonstrate species (i.e., genetic) differences in the response to TD-induced damage and support a role for APP and APLP2 in the response to brain injury. This is the first report that chronic oxidative deficits can lead to this novel pathology.

Full text

PDF
1063

Images in this article

1066Figure 1
on p.1066
1067Figure 2
on p.1067

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arendt T., Bigl V., Arendt A., Tennstedt A. Loss of neurons in the nucleus basalis of Meynert in Alzheimer's disease, paralysis agitans and Korsakoff's Disease. Acta Neuropathol. 1983;61(2):101–108. doi: 10.1007/BF00697388. [DOI] [PubMed] [Google Scholar]
  2. BURGESS R. C., PLATT B. S., FOLLIS R. H., Jr, HANDLER P., DENNY-BROWN D., AYKROYD W. R. Beriberi. Fed Proc. 1958 Sep;17(3):3–56. [PubMed] [Google Scholar]
  3. Barclay L. L., Gibson G. E., Blass J. P. Impairment of behavior and acetylcholine metabolism in thiamine deficiency. J Pharmacol Exp Ther. 1981 Jun;217(3):537–543. [PubMed] [Google Scholar]
  4. Bhasin R., Van Nostrand W. E., Saitoh T., Donets M. A., Barnes E. A., Quitschke W. W., Goldgaber D. Expression of active secreted forms of human amyloid beta-protein precursor by recombinant baculovirus-infected insect cells. Proc Natl Acad Sci U S A. 1991 Nov 15;88(22):10307–10311. doi: 10.1073/pnas.88.22.10307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Blass J. P., Gibson G. E. Abnormality of a thiamine-requiring enzyme in patients with Wernicke-Korsakoff syndrome. N Engl J Med. 1977 Dec 22;297(25):1367–1370. doi: 10.1056/NEJM197712222972503. [DOI] [PubMed] [Google Scholar]
  6. Burke J. R., Enghild J. J., Martin M. E., Jou Y. S., Myers R. M., Roses A. D., Vance J. M., Strittmatter W. J. Huntingtin and DRPLA proteins selectively interact with the enzyme GAPDH. Nat Med. 1996 Mar;2(3):347–350. doi: 10.1038/nm0396-347. [DOI] [PubMed] [Google Scholar]
  7. Butterworth R. F. Cerebral thiamine-dependent enzyme changes in experimental Wernicke's encephalopathy. Metab Brain Dis. 1986 Sep;1(3):165–175. doi: 10.1007/BF01001778. [DOI] [PubMed] [Google Scholar]
  8. Buxbaum J. D., Gandy S. E., Cicchetti P., Ehrlich M. E., Czernik A. J., Fracasso R. P., Ramabhadran T. V., Unterbeck A. J., Greengard P. Processing of Alzheimer beta/A4 amyloid precursor protein: modulation by agents that regulate protein phosphorylation. Proc Natl Acad Sci U S A. 1990 Aug;87(15):6003–6006. doi: 10.1073/pnas.87.15.6003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Calingasan N. Y., Baker H., Sheu K. F., Gibson G. E. Blood-brain barrier abnormalities in vulnerable brain regions during thiamine deficiency. Exp Neurol. 1995 Jul;134(1):64–72. doi: 10.1006/exnr.1995.1037. [DOI] [PubMed] [Google Scholar]
  10. Calingasan N. Y., Gandy S. E., Baker H., Sheu K. F., Kim K. S., Wisniewski H. M., Gibson G. E. Accumulation of amyloid precursor protein-like immunoreactivity in rat brain in response to thiamine deficiency. Brain Res. 1995 Apr 17;677(1):50–60. doi: 10.1016/0006-8993(95)00136-e. [DOI] [PubMed] [Google Scholar]
  11. Caporaso G. L., Gandy S. E., Buxbaum J. D., Greengard P. Chloroquine inhibits intracellular degradation but not secretion of Alzheimer beta/A4 amyloid precursor protein. Proc Natl Acad Sci U S A. 1992 Mar 15;89(6):2252–2256. doi: 10.1073/pnas.89.6.2252. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Coyle J. T., Price D. L., DeLong M. R. Alzheimer's disease: a disorder of cortical cholinergic innervation. Science. 1983 Mar 11;219(4589):1184–1190. doi: 10.1126/science.6338589. [DOI] [PubMed] [Google Scholar]
  13. Cullen K. M., Halliday G. M. Mechanisms of cell death in cholinergic basal forebrain neurons in chronic alcoholics. Metab Brain Dis. 1995 Mar;10(1):81–91. doi: 10.1007/BF01991785. [DOI] [PubMed] [Google Scholar]
  14. Cullen K. M., Halliday G. M. Neurofibrillary tangles in chronic alcoholics. Neuropathol Appl Neurobiol. 1995 Aug;21(4):312–318. doi: 10.1111/j.1365-2990.1995.tb01065.x. [DOI] [PubMed] [Google Scholar]
  15. Games D., Adams D., Alessandrini R., Barbour R., Berthelette P., Blackwell C., Carr T., Clemens J., Donaldson T., Gillespie F. Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein. Nature. 1995 Feb 9;373(6514):523–527. doi: 10.1038/373523a0. [DOI] [PubMed] [Google Scholar]
  16. Gandy S. E., Bhasin R., Ramabhadran T. V., Koo E. H., Price D. L., Goldgaber D., Greengard P. Alzheimer beta/A4-amyloid precursor protein: evidence for putative amyloidogenic fragment. J Neurochem. 1992 Jan;58(1):383–386. doi: 10.1111/j.1471-4159.1992.tb09322.x. [DOI] [PubMed] [Google Scholar]
  17. Gibson G. E., Ksiezak-Reding H., Sheu K. F., Mykytyn V., Blass J. P. Correlation of enzymatic, metabolic, and behavioral deficits in thiamin deficiency and its reversal. Neurochem Res. 1984 Jun;9(6):803–814. doi: 10.1007/BF00965667. [DOI] [PubMed] [Google Scholar]
  18. Gibson G. E., Sheu K. F., Blass J. P., Baker A., Carlson K. C., Harding B., Perrino P. Reduced activities of thiamine-dependent enzymes in the brains and peripheral tissues of patients with Alzheimer's disease. Arch Neurol. 1988 Aug;45(8):836–840. doi: 10.1001/archneur.1988.00520320022009. [DOI] [PubMed] [Google Scholar]
  19. Godfrey P. P., Wilkins C. J., Tyler W., Watson S. P. Stimulatory and inhibitory actions of excitatory amino acids on inositol phospholipid metabolism in rat cerebral cortex. Br J Pharmacol. 1988 Sep;95(1):131–138. doi: 10.1111/j.1476-5381.1988.tb16556.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Guntern R., Bouras C., Hof P. R., Vallet P. G. An improved thioflavine S method for staining neurofibrillary tangles and senile plaques in Alzheimer's disease. Experientia. 1992 Jan 15;48(1):8–10. doi: 10.1007/BF01923594. [DOI] [PubMed] [Google Scholar]
  21. Haass C., Hung A. Y., Selkoe D. J. Processing of beta-amyloid precursor protein in microglia and astrocytes favors an internal localization over constitutive secretion. J Neurosci. 1991 Dec;11(12):3783–3793. doi: 10.1523/JNEUROSCI.11-12-03783.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Haass C., Schlossmacher M. G., Hung A. Y., Vigo-Pelfrey C., Mellon A., Ostaszewski B. L., Lieberburg I., Koo E. H., Schenk D., Teplow D. B. Amyloid beta-peptide is produced by cultured cells during normal metabolism. Nature. 1992 Sep 24;359(6393):322–325. doi: 10.1038/359322a0. [DOI] [PubMed] [Google Scholar]
  23. Hajimohammadreza I., Anderson V. E., Cavanagh J. B., Seville M. P., Nolan C. C., Anderton B. H., Leigh P. N. beta-Amyloid precursor protein fragments and lysosomal dense bodies are found in rat brain neurons after ventricular infusion of leupeptin. Brain Res. 1994 Mar 21;640(1-2):25–32. doi: 10.1016/0006-8993(94)91853-8. [DOI] [PubMed] [Google Scholar]
  24. Hsu S. M., Raine L., Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem. 1981 Apr;29(4):577–580. doi: 10.1177/29.4.6166661. [DOI] [PubMed] [Google Scholar]
  25. Iverfeldt K., Walaas S. I., Greengard P. Altered processing of Alzheimer amyloid precursor protein in response to neuronal degeneration. Proc Natl Acad Sci U S A. 1993 May 1;90(9):4146–4150. doi: 10.1073/pnas.90.9.4146. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Kalaria R. N., Bhatti S. U., Palatinsky E. A., Pennington D. H., Shelton E. R., Chan H. W., Perry G., Lust W. D. Accumulation of the beta amyloid precursor protein at sites of ischemic injury in rat brain. Neuroreport. 1993 Feb;4(2):211–214. doi: 10.1097/00001756-199302000-00025. [DOI] [PubMed] [Google Scholar]
  27. Kang J., Lemaire H. G., Unterbeck A., Salbaum J. M., Masters C. L., Grzeschik K. H., Multhaup G., Beyreuther K., Müller-Hill B. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature. 1987 Feb 19;325(6106):733–736. doi: 10.1038/325733a0. [DOI] [PubMed] [Google Scholar]
  28. Lamb B. T., Sisodia S. S., Lawler A. M., Slunt H. H., Kitt C. A., Kearns W. G., Pearson P. L., Price D. L., Gearhart J. D. Introduction and expression of the 400 kilobase amyloid precursor protein gene in transgenic mice [corrected]. Nat Genet. 1993 Sep;5(1):22–30. doi: 10.1038/ng0993-22. [DOI] [PubMed] [Google Scholar]
  29. Langlais P. J., Savage L. M. Thiamine deficiency in rats produces cognitive and memory deficits on spatial tasks that correlate with tissue loss in diencephalon, cortex and white matter. Behav Brain Res. 1995 Apr;68(1):75–89. doi: 10.1016/0166-4328(94)00162-9. [DOI] [PubMed] [Google Scholar]
  30. Masliah E., Mallory M., Hansen L., Alford M., DeTeresa R., Terry R. An antibody against phosphorylated neurofilaments identifies a subset of damaged association axons in Alzheimer's disease. Am J Pathol. 1993 Mar;142(3):871–882. [PMC free article] [PubMed] [Google Scholar]
  31. McFarland D. J. Mouse phenotype modulates the behavioral effects of acute thiamine deficiency. Physiol Behav. 1985 Oct;35(4):597–601. doi: 10.1016/0031-9384(85)90147-7. [DOI] [PubMed] [Google Scholar]
  32. Munoz D. G., Wang D. Tangle-associated neuritic clusters. A new lesion in Alzheimer's disease and aging suggests that aggregates of dystrophic neurites are not necessarily associated with beta/A4. Am J Pathol. 1992 May;140(5):1167–1178. [PMC free article] [PubMed] [Google Scholar]
  33. Nordstedt C., Gandy S. E., Alafuzoff I., Caporaso G. L., Iverfeldt K., Grebb J. A., Winblad B., Greengard P. Alzheimer beta/A4 amyloid precursor protein in human brain: aging-associated increases in holoprotein and in a proteolytic fragment. Proc Natl Acad Sci U S A. 1991 Oct 15;88(20):8910–8914. doi: 10.1073/pnas.88.20.8910. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Otsuka N., Tomonaga M., Ikeda K. Rapid appearance of beta-amyloid precursor protein immunoreactivity in damaged axons and reactive glial cells in rat brain following needle stab injury. Brain Res. 1991 Dec 24;568(1-2):335–338. doi: 10.1016/0006-8993(91)91422-w. [DOI] [PubMed] [Google Scholar]
  35. Pappolla M. A., Omar R. A., Kim K. S., Robakis N. K. Immunohistochemical evidence of oxidative [corrected] stress in Alzheimer's disease. Am J Pathol. 1992 Mar;140(3):621–628. [PMC free article] [PubMed] [Google Scholar]
  36. Plump A. S., Smith J. D., Hayek T., Aalto-Setälä K., Walsh A., Verstuyft J. G., Rubin E. M., Breslow J. L. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell. 1992 Oct 16;71(2):343–353. doi: 10.1016/0092-8674(92)90362-g. [DOI] [PubMed] [Google Scholar]
  37. Reuler J. B., Girard D. E., Cooney T. G. Current concepts. Wernicke's encephalopathy. N Engl J Med. 1985 Apr 18;312(16):1035–1039. doi: 10.1056/NEJM198504183121606. [DOI] [PubMed] [Google Scholar]
  38. Saunders A. M., Strittmatter W. J., Schmechel D., George-Hyslop P. H., Pericak-Vance M. A., Joo S. H., Rosi B. L., Gusella J. F., Crapper-MacLachlan D. R., Alberts M. J. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology. 1993 Aug;43(8):1467–1472. doi: 10.1212/wnl.43.8.1467. [DOI] [PubMed] [Google Scholar]
  39. Shigematsu K., McGeer P. L. Accumulation of amyloid precursor protein in neurons after intraventricular injection of colchicine. Am J Pathol. 1992 Apr;140(4):787–794. [PMC free article] [PubMed] [Google Scholar]
  40. Sisodia S. S., Koo E. H., Hoffman P. N., Perry G., Price D. L. Identification and transport of full-length amyloid precursor proteins in rat peripheral nervous system. J Neurosci. 1993 Jul;13(7):3136–3142. doi: 10.1523/JNEUROSCI.13-07-03136.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Slunt H. H., Thinakaran G., Von Koch C., Lo A. C., Tanzi R. E., Sisodia S. S. Expression of a ubiquitous, cross-reactive homologue of the mouse beta-amyloid precursor protein (APP). J Biol Chem. 1994 Jan 28;269(4):2637–2644. [PubMed] [Google Scholar]
  42. Smith M. A., Kutty R. K., Richey P. L., Yan S. D., Stern D., Chader G. J., Wiggert B., Petersen R. B., Perry G. Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer's disease. Am J Pathol. 1994 Jul;145(1):42–47. [PMC free article] [PubMed] [Google Scholar]
  43. Smith M. A., Sayre L. M., Monnier V. M., Perry G. Radical AGEing in Alzheimer's disease. Trends Neurosci. 1995 Apr;18(4):172–176. doi: 10.1016/0166-2236(95)93897-7. [DOI] [PubMed] [Google Scholar]
  44. Strittmatter W. J., Saunders A. M., Schmechel D., Pericak-Vance M., Enghild J., Salvesen G. S., Roses A. D. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci U S A. 1993 Mar 1;90(5):1977–1981. doi: 10.1073/pnas.90.5.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Strittmatter W. J., Weisgraber K. H., Huang D. Y., Dong L. M., Salvesen G. S., Pericak-Vance M., Schmechel D., Saunders A. M., Goldgaber D., Roses A. D. Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease. Proc Natl Acad Sci U S A. 1993 Sep 1;90(17):8098–8102. doi: 10.1073/pnas.90.17.8098. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Suzuki T., Nairn A. C., Gandy S. E., Greengard P. Phosphorylation of Alzheimer amyloid precursor protein by protein kinase C. Neuroscience. 1992 Jun;48(4):755–761. doi: 10.1016/0306-4522(92)90264-3. [DOI] [PubMed] [Google Scholar]
  47. Takemura M., Nakamura S., Akiguchi I., Ueno M., Oka N., Ishikawa S., Shimada A., Kimura J., Takeda T. Beta/A4 proteinlike immunoreactive granular structures in the brain of senescence-accelerated mouse. Am J Pathol. 1993 Jun;142(6):1887–1897. [PMC free article] [PubMed] [Google Scholar]
  48. Terry R. D., Katzman R. Senile dementia of the Alzheimer type. Ann Neurol. 1983 Nov;14(5):497–506. doi: 10.1002/ana.410140502. [DOI] [PubMed] [Google Scholar]
  49. Thinakaran G., Kitt C. A., Roskams A. J., Slunt H. H., Masliah E., von Koch C., Ginsberg S. D., Ronnett G. V., Reed R. R., Price D. L. Distribution of an APP homolog, APLP2, in the mouse olfactory system: a potential role for APLP2 in axogenesis. J Neurosci. 1995 Oct;15(10):6314–6326. doi: 10.1523/JNEUROSCI.15-10-06314.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Thinakaran G., Sisodia S. S. Amyloid precursor-like protein 2 (APLP2) is modified by the addition of chondroitin sulfate glycosaminoglycan at a single site. J Biol Chem. 1994 Sep 2;269(35):22099–22104. [PubMed] [Google Scholar]
  51. Vorhees C. V., Schmidt D. E., Barrett R. J. Effects of pyrithiamin and oxythiamin on acetylcholine levels and utilization in rat brain. Brain Res Bull. 1978 Sep-Oct;3(5):493–496. doi: 10.1016/0361-9230(78)90078-3. [DOI] [PubMed] [Google Scholar]
  52. Wasco W., Gurubhagavatula S., Paradis M. D., Romano D. M., Sisodia S. S., Hyman B. T., Neve R. L., Tanzi R. E. Isolation and characterization of APLP2 encoding a homologue of the Alzheimer's associated amyloid beta protein precursor. Nat Genet. 1993 Sep;5(1):95–100. doi: 10.1038/ng0993-95. [DOI] [PubMed] [Google Scholar]
  53. Watanabe I., Kanabe S. Early edematous lesion of pyrithiamine induced acute thiamine deficient encephalopathy in the mouse. J Neuropathol Exp Neurol. 1978 Jul-Aug;37(4):401–413. doi: 10.1097/00005072-197807000-00004. [DOI] [PubMed] [Google Scholar]
  54. Watanabe I. Pyrithiamine-induced acute thiamine-deficient encephalopathy in the mouse. Exp Mol Pathol. 1978 Jun;28(3):381–394. doi: 10.1016/0014-4800(78)90012-6. [DOI] [PubMed] [Google Scholar]
  55. Watanabe I., Tomita T., Hung K. S., Iwasaki Y. Edematous necrosis in thiamine-deficient encephalopathy of the mouse. J Neuropathol Exp Neurol. 1981 Jul;40(4):454–471. doi: 10.1097/00005072-198107000-00008. [DOI] [PubMed] [Google Scholar]
  56. Witt E. D. Neuroanatomical consequences of thiamine deficiency: a comparative analysis. Alcohol Alcohol. 1985;20(2):201–221. [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES